Technical Analysis for ENTA - Enanta Pharmaceuticals, Inc.

Grade Last Price % Change Price Change
grade D 75.37 -2.08% -1.60
ENTA closed down 2.08 percent on Wednesday, November 14, 2018, on approximately normal volume. The stock exhibited some range contraction during this trading session as price made an NR7 -- narrowest range of the last seven sessions.

Earnings due: Nov 19

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Strong Down Down Down
See historical ENTA trend table...

Date Alert Name Type % Chg
Nov 14 20 DMA Resistance Bearish 0.00%
Nov 14 NR7 Range Contraction 0.00%
Nov 13 20 DMA Resistance Bearish -2.08%
Nov 12 20 DMA Resistance Bearish -1.77%
Nov 12 Outside Day Range Expansion -1.77%
Nov 9 Fell Below 20 DMA Bearish -0.84%
Nov 9 New Downtrend Bearish -0.84%
Nov 9 NR7 Range Contraction -0.84%
Nov 8 Fell Below 50 DMA Bearish -3.63%
Nov 8 20 DMA Support Bullish -3.63%

Older signals for ENTA ...

Get a Trading Sidekick!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:
Profile
Enanta Pharmaceuticals, Inc., a biotechnology company, engages in the development of small molecule drugs for the infectious disease areas. Its product candidates include ABT-450, an inhibitor of NS3 protease that is in Phase III clinical trials for the treatment of hepatitis C virus (HCV) infection; EDP-239, an NS5A Inhibitor for HCV infection; EDP-546, a Cyclophilin inhibitor, which is in preclinical studies for HCV infection treatment; and Nucleotide Polymerase inhibitor for HCV infection. The company also develops EDP-788, an intravenous drug for the treatment of methicillin-resistant Staphylococcus aureus bacteria. It has collaboration and license agreements with Novartis Institutes for BioMedical Research, Inc. and Abbott Laboratories. The company was founded in 1995 and is headquartered in Watertown, Massachusetts.
Is ENTA a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 0 bullish, 4 bearish and 1 neutral indicators. You may wish to incorporate that into your trading strategies.
Indicators
Indicator Value
52 Week High 127.77
52 Week Low 44.52
Average Volume 267,100
200-Day Moving Average 92.7646
50-Day Moving Average 81.9846
20-Day Moving Average 77.484
10-Day Moving Average 78.863
Average True Range 4.2014
ADX 26.78
+DI 18.1731
-DI 21.4913
Chandelier Exit (Long, 3 ATRs ) 73.7158
Chandelier Exit (Short, 3 ATRs ) 82.9942
Upper Bollinger Band 83.3043
Lower Bollinger Band 71.6637
Percent B (%b) 0.32
BandWidth 15.023231
MACD Line -1.1025
MACD Signal Line -1.2555
MACD Histogram 0.153
Fundamentals Value
Market Cap 1.44 Billion
Num Shares 19.1 Million
EPS -1.08
Price-to-Earnings (P/E) Ratio -69.79
Price-to-Sales 23.12
Price-to-Book 3.52
PEG Ratio 0.00
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 79.45
Resistance 3 (R3) 79.79 78.76 78.77
Resistance 2 (R2) 78.76 77.72 78.60 78.54
Resistance 1 (R1) 77.07 77.08 76.56 76.73 78.32
Pivot Point 76.04 76.04 75.79 75.88 76.04
Support 1 (S1) 74.35 75.00 73.84 74.01 72.42
Support 2 (S2) 73.32 74.36 73.16 72.20
Support 3 (S3) 71.63 73.32 71.97
Support 4 (S4) 71.29